Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
07/09/2003 | EP1325010A1 Substituted 3.4-dihydro-pyrimido 1,2-a]pyrimidines and 3.4-dihydropyrazino 1,2-a]pyrimidines |
07/09/2003 | EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
07/09/2003 | EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
07/09/2003 | EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions |
07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
07/09/2003 | EP1324771A2 Therapeutic antibodies |
07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
07/09/2003 | EP1324756A2 Fatty acid analogues for the treatment of proliferative skin disorders |
07/09/2003 | EP1324750A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
07/09/2003 | EP1324745A1 Cosmetic or dermatological formulations containing aminoguanidine |
07/09/2003 | EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
07/09/2003 | EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
07/09/2003 | EP0686194B1 Harp family growth factors, preparation methods therefor and uses thereof |
07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
07/09/2003 | CN1429209A Disulfide derivatives useful for treating allergic diseases |
07/09/2003 | CN1429208A Aniline disulfide derivatives for treating allergic diseases |
07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
07/09/2003 | CN1429105A Dermal compositions containing coenzyme Q as active ingredient |
07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
07/09/2003 | CN1429098A 乳化组合物 Emulsified composition |
07/09/2003 | CN1429097A Use of ellagic acid as anti-pollution cosmetic agent |
07/09/2003 | CN1428413A Hair-nourishing hair-growing liquor |
07/09/2003 | CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
07/09/2003 | CN1428160A Hair-growing liquor |
07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
07/09/2003 | CN1113862C Arysulfonylamino hydroxamic acid derivs. |
07/09/2003 | CN1113668C Chinese-medicinal composition for curing acne, removing spots and beautifying and whitening face |
07/09/2003 | CN1113662C Compound red and yellow psoriasis capsule |
07/09/2003 | CN1113660C Exterior-applied medicine for treating acne and its preparing method |
07/09/2003 | CN1113648C Use of tetrahydro-beta-carboline derivative as antimetastatic carcinoma preparation |
07/08/2003 | US6590105 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits |
07/08/2003 | US6590085 Derivatives of monosaccharides as cell adhesion inhibitors |
07/08/2003 | US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
07/08/2003 | US6589989 Treating chronic hand eczema in a human patient in need of treatment, using oral administration of 9-cis retinoic acid and pharmaceutically acceptable salts and pharmaceutically acceptable hydrolysable esters thereof, in an effective |
07/08/2003 | US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell |
07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
07/08/2003 | US6589950 Treatment of inflammatory or obstructive airways disease for respiratory system disorders |
07/08/2003 | US6589948 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
07/08/2003 | US6589945 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
07/08/2003 | US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
07/08/2003 | US6589564 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate |
07/08/2003 | US6589540 Cosmetic composition for skin care containing retinol and epidermal growth factor |
07/08/2003 | US6589520 Treatment of psoriasis, allergies and auto-immune disorders of the skin with cis-6-hexadecenoic acid |
07/08/2003 | US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
07/08/2003 | CA2233222C Skin treatment with salicylic acid esters and retinoids |
07/08/2003 | CA2182715C Cationic biopolymers |
07/03/2003 | WO2003054200A1 Chitosanase and use thereof |
07/03/2003 | WO2003054012A2 Leptin proteins |
07/03/2003 | WO2003054009A2 Apoptotically active peptides |
07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
07/03/2003 | WO2003053991A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases |
07/03/2003 | WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity |
07/03/2003 | WO2003053973A1 Pyrazolyl-substituted triazoloquinoxalines |
07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
07/03/2003 | WO2003053967A1 Aroyl pyridinones |
07/03/2003 | WO2003053957A1 Benzhydryl derivatives |
07/03/2003 | WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists |
07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
07/03/2003 | WO2003053467A1 Drug for regenerating tissue and vessel and method therefor |
07/03/2003 | WO2003053466A1 Skin barrier function repair accelerators |
07/03/2003 | WO2003053458A1 Use of a pharmaceutical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
07/03/2003 | WO2003053446A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
07/03/2003 | WO2003053444A1 New use |
07/03/2003 | WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
07/03/2003 | WO2003053407A1 Liposomal delivery of vitamin e based compounds |
07/03/2003 | WO2003053393A1 Cosmetic and dermatological light-protective formulations comprising hydroxybenzophenones and benzoxazole derivatives |
07/03/2003 | WO2003053376A1 Yeast-based curative and care product and method for making same |
07/03/2003 | WO2003053374A1 Use of an extract of the baptisia tinctoria plant in a cosmetic composition |
07/03/2003 | WO2003053368A2 Chalcone derivatives and their use to treat diseases |
07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
07/03/2003 | WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
07/03/2003 | WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function |
07/03/2003 | WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells |
07/03/2003 | WO2003053336A2 Methods for the treatment of peripheral neural and vascular ailments |
07/03/2003 | WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor |
07/03/2003 | WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3 |
07/03/2003 | WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
07/03/2003 | WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders |
07/03/2003 | WO2003026643A3 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
07/03/2003 | WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor |
07/03/2003 | WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
07/03/2003 | WO2002020849A3 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
07/03/2003 | US20030125800 Drug-delivery endovascular stent and method for treating restenosis |
07/03/2003 | US20030125615 Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
07/03/2003 | US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder |
07/03/2003 | US20030125532 Kneading then irradiating paste to form elastic gel; microbiocides |
07/03/2003 | US20030125523 Novel neuropilin/growth factor complexes and uses thereof |
07/03/2003 | US20030125388 5-Aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
07/03/2003 | US20030125383 For treating or preventing emphysema, cancer and dermatological disorders |
07/03/2003 | US20030125378 Skin treatment, cosmetics |
07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |
07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
07/03/2003 | US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |